Sorafenib for HCC: A pragmatic perspective

Oncology

Volumn 25, Issue 3, 2011, Pages

  Razumilava, Nataliya ^a   Gores, Gregory J ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EVEROLIMUS; SORAFENIB;

CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; DECOMPENSATED LIVER CIRRHOSIS; DISEASE CLASSIFICATION; DISEASE SEVERITY; DRUG INDICATION; DRUG USE; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER TOXICITY; LOCAL THERAPY; MONOTHERAPY; NOTE; UNSPECIFIED SIDE EFFECT;

EID: 79953121519     PISSN: 08909091     EISSN: 08909091     Source Type: Journal    
DOI: None     Document Type: Note

References (0)